BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malaguarnera M, Di Fazio I, Restuccia S, Pistone G, Restuccia N, Trovato BA. Efficacy of different schedules in the management of chronic hepatitis C with interferon-alpha. Ann Med. 1998;30:213-217. [PMID: 9667801 DOI: 10.3109/07853899808999406] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Tinè F, Attanasio M, Russo F, Pagliaro L. A decade of trials of interferon-alpha for chronic hepatitis C. A meta-regression analysis. Contemp Clin Trials 2005;26:179-210. [PMID: 15837440 DOI: 10.1016/j.cct.2004.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
2 Fazio ID, Motta M, Musumeci S, Neri S, Pistone G, Malaguarnera M. Efficacy of Human Recombinant Erythropoietin plus IFN-α in Patients Affected by Chronic Hepatitis C. Journal of Interferon & Cytokine Research 2004;24:594-9. [DOI: 10.1089/jir.2004.24.594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
3 Malaguarnera M, Vacante M, Giordano M, Motta M, Bertino G, Pennisi M, Neri S, Malaguarnera M, Volti GL, Galvano F. L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol 2011; 17(39): 4414-4420 [PMID: 22110268 DOI: 10.3748/wjg.v17.i39.4414] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
4 Foster GR. Review article: pegylated interferons: chemical and clinical differences. Aliment Pharmacol Ther. 2004;20:825-830. [PMID: 15479353 DOI: 10.1111/j.1365-2036.2004.02170.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 4.3] [Reference Citation Analysis]
5 Romano M, Vacante M, Cristaldi E, Colonna V, Gargante MP, Cammalleri L, Malaguarnera M. L-carnitine treatment reduces steatosis in patients with chronic hepatitis C treated with alpha-interferon and ribavirin. Dig Dis Sci. 2008;53:1114-1121. [PMID: 17939042 DOI: 10.1007/s10620-007-9983-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
6 Kurz K, Schroecksnadel S, Weiss G, Fuchs D. Association between increased tryptophan degradation and depression in cancer patients. Curr Opin Clin Nutr Metab Care 2011;14:49-56. [PMID: 21076293 DOI: 10.1097/MCO.0b013e328340d849] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]